Provider-directed options that may support this treatment goal. Every plan is individualized and requires a live consultation with a licensed VidaVital medical provider.
These pathways describe options your VidaVital medical provider may discuss with you based on your history, goals, and laboratory results. Advanced is not "better" than Beginner — it involves more therapies, more monitoring, and more provider oversight.
The simplest starting point: a single provider-selected incretin therapy alongside nutrition and activity guidance.
Adds a second mechanism — a growth-hormone-axis pairing when clinically appropriate for lean-mass preservation.
A broader strategy for patients whose provider identifies multiple contributing factors or who have not adequately responded to simpler treatment.
A provider-directed GLP-1 receptor agonist that may support medical weight management, appetite regulation, and blood sugar control.
A provider-directed dual GLP-1 and GIP receptor agonist that may support medical weight management and blood sugar control.
A compounded, investigational peptide fragment of human growth hormone being evaluated for body composition support alongside medical weight management.
A growth-hormone-releasing hormone (GHRH) analog. FDA-approved only for reducing excess abdominal fat in adults with HIV-associated lipodystrophy; any other use is off-label.
A compounded combination of a short-acting GHRH analog (CJC-1295 no DAC) and a growth-hormone secretagogue (ipamorelin) that some providers use to support the growth-hormone axis.
Speak with a licensed VidaVital provider about your goals, medical history, and laboratory results. Your provider will determine whether any of these therapies are appropriate for you.
The information provided on this website is for general educational purposes and is not medical advice, a diagnosis, or a prescription. Treatment recommendations are not final until a licensed medical provider completes a live consultation, reviews your medical history and medications, evaluates relevant laboratory results, and determines that treatment is medically appropriate.
Certain treatments may be prepared by a compounding pharmacy pursuant to an individual prescription. Compounded medications are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing.
Your results identify subjects to discuss with a provider. They do not establish medical eligibility or guarantee that any medication will be prescribed.
This website is not intended for emergencies. Call 911 or seek immediate medical attention for urgent or severe symptoms.
